Concomitant prescription of psychotropic and cardiovascular drugs in elderly patients

Figures & data

Figure 1. Prescription of cardiovascular and psychotropic drugs in elderly patients, stratified by age. CON: concomitant prescription of cardiovascular and psychotropic drugs; C: cardiovascular drug prescription; P: psychotropic drug prescription; NO: no prescription of cardiovascular and psychotropic drugs.

Table 1. Characteristics of patients.

	CON	C	P	NO	p value
Male (%)	51 (37.8)	56 (28.2)	38 (11.9)	19 (7.8)	.0019^a
Mean age in years (min–max)	73 (65–83)	75 (65–92)	74 (65–98)	71 (65–92)	<.001^b
Mean number of drugs (min–max)	6.2 (2–13)	4.1 (1–9)	4 (1–11)	2.6 (0–11)	<.001^b

Note: CON: concomitant prescription of cardiovascular and psychotropic drugs; C: cardiovascular drug prescription; P: psychotropic drug prescription; NO: no prescription of cardiovascular and psychotropic drugs.

^aChi-square test.

^bANOVA.

Table 2. Psychotropic drug prescription.

Drugs	CON, n = 135 (%)	P, n = 406 (%)
Antipsychotics	59 (43.7)	206 (50.7)
Antidepressants	64 (47.4)	209 (51.4)
Anxiolytics	38 (28.1)	118 (29.0)
Other	16 (11.8)	58 (14.2)

Note: CON: concomitant prescription of cardiovascular and psychotropic drugs; P: psychotropic drug prescription

Table 3. Cardiovascular drug prescription.

Drugs	CON, n = 135 (%)	C, n = 198 (%)
ASA	50 (37.0)	81 (40.9)
Nitrates	14 (10.3)	31 (15.6)
Beta blockers	40 (29.6)	56 (28.2)
ACEI	62 (45.9)	94 (47.4)
CCB	34 (25.1)	53 (26.7)
Diuretics	72 (53.3)	101 (51.0)
Digitalis	19 (14.0)	21 (10.6)
LLD	52 (38.5)	67 (33.8)
ARB	43 (31.8)	73 (36.8)

Note: CON: concomitant prescription of cardiovascular and psychotropic drugs; C: cardiovascular drug prescription; ASA: acetylsalicylic acid; ACEI: angiotensin-converting enzyme inhibitors; CCB: calcium channel blockers; LLD: lipid-lowering drugs; ARB: angiotensin II receptor blockers.